Syn-Med-Chemist-"Quintessential Synthetic Chemistry"---A Synthetic Chemist's Perception......
Friday, December 26, 2014
Kinex Pharmaceuticals doses first patient with KX2-361 in ‘A Phase 1’ clinical trial
Kinex Pharmaceuticals doses first patient with KX2-361 in ‘A Phase 1’ clinical trial
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment